MSB vs TRU

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

38LOW

TRU

TRUSCREEN FPO NZX [TRU]

38LOW

Score Breakdown

MSB TRU
Technical
55
44
Catalyst
54
50
Sentiment
50
50
Fundamental
66
28
Momentum
67
40
Risk Gate
40
35

Key Metrics

MSB Metric TRU
$2.7BMarket Cap$9.7M
4.4MAvg Volume (20d)297K
+8.3%Short InterestN/A
$3.31052-Week High$0.029
$1.51552-Week Low$0.012
+6.3%Daily Change+8.3%
$2.190Entry Price$0.013
-18.2%ROE-90.8%
-144.3%Profit Margin-135.5%

Active Signals

MSB Signals

●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Strong revenue growth (+1527%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

TRU Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Took a hit — down 13.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (3 quarters) - dilution risk
●Moderate P/S ratio (5.3x)
●Revenue in sharp decline (-20%)

Ask Scout AI to compare MSB and TRU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MSB Full Analysis → TRU Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).